- GlobeNewswire•2 hours agoLESS THAN 2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Expanded Class Period and Reminds Them of Lead Plaintiff Deadline
SAN FRANCISCO, Jan. 24, 2017-- Hagens Berman Sobol Shapiro LLP alerts investors in Novo Nordisk A/S to the expanded class period and reminds them of the March 13, 2017 Lead Plaintiff deadline.. If you ...
- Accesswire•yesterdaySHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017
NEW YORK, NY / ACCESSWIRE / January 23, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") ...
- Marketwired•4 days agoNOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S - (NVO)
Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 13, 2017 to file lead plaintiff applications in a securities ...
NVO : Summary for Novo Nordisk A/S Common Stock - Yahoo Finance
Novo Nordisk A/S (NVO)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||34.58 - 35.04|
|52 Week Range||30.89 - 57.81|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.60|
|Dividend & Yield||1.41 (3.97%)|
|1y Target Est||N/A|